Join a Clinical Trial
Whether you are eligible for a research study depends on many things. There are specific requirements to be in research studies. These requirements are different for each clinical trial.
Clinical Trial Details
Endocrine Response in Women With Invasive Lobular Breast Cancer
Complete Title: A Trial of Endocrine Response in Women with Invasive Lobular Breast Cancer
Trial Phase: II
Investigator: Hannah Linden, MD
To study whether fulvestrant is more effective than anastrozole or tamoxifen in reducing Ki67 in ILC and whether that Ki67 reduction will correlate with alterations in expression of ER and ER-regulated genes. Differential Ki67 effect in this study will serve as a surrogate for outcome of ILC patients on endocrine therapy.
Keywords:
- Breast Cancer
- Solid Tumors
Disclaimer: We update this information regularly. However, what you read today may not be completely up to date.
Contact Us
If you are seeking to schedule an appointment, we are here to help. You can either call us or fill out our online appointment request form.
Adult
Pediatric
II
Hannah Linden, MD
9743
NCT02206984
A Trial of Endocrine Response in Women with Invasive Lobular Breast Cancer
Breast Cancer
Solid Tumors